- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.55 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x CA: CALCIUM ION(Non-covalent)
- 8 x LXC: beta-L-xylopyranose(Non-covalent)
LXC.3: 6 residues within 4Å:- Chain A: D.295
- Chain D: A.332, R.334, R.368, G.369, A.371
6 PLIP interactions:3 interactions with chain D, 3 interactions with chain A- Hydrogen bonds: D:A.332, D:G.369, A:D.295, A:D.295
- Salt bridges: D:R.334
- Water bridges: A:D.297
LXC.4: 11 residues within 4Å:- Chain A: H.54, T.90, F.94, W.137, E.181, E.217, H.220, D.245, D.287
- Chain C: F.26
- Ligands: CA.1
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:H.54, A:E.181, A:H.220
- Water bridges: A:N.215, A:N.215
- Salt bridges: A:H.54, A:K.289
LXC.36: 6 residues within 4Å:- Chain B: D.295
- Chain C: A.332, R.334, R.368, G.369, A.371
4 PLIP interactions:3 interactions with chain C, 1 interactions with chain B- Hydrogen bonds: C:A.332, C:G.369, B:D.295
- Salt bridges: C:R.334
LXC.37: 11 residues within 4Å:- Chain B: H.54, T.90, F.94, W.137, E.181, E.217, H.220, D.245, D.287
- Chain D: F.26
- Ligands: CA.34
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:H.54, B:T.90, B:E.181, B:H.220
- Water bridges: B:N.215, B:N.215
- Salt bridges: B:H.54, B:K.289
LXC.69: 6 residues within 4Å:- Chain B: A.332, R.334, R.368, G.369, A.371
- Chain C: D.295
4 PLIP interactions:3 interactions with chain B, 1 interactions with chain C- Hydrogen bonds: B:A.332, B:G.369, C:D.295
- Salt bridges: B:R.334
LXC.70: 11 residues within 4Å:- Chain A: F.26
- Chain C: H.54, T.90, F.94, W.137, E.181, E.217, H.220, D.245, D.287
- Ligands: CA.67
8 PLIP interactions:8 interactions with chain C- Hydrogen bonds: C:H.54, C:T.90, C:E.181, C:H.220
- Water bridges: C:N.215, C:N.215
- Salt bridges: C:H.54, C:K.289
LXC.102: 6 residues within 4Å:- Chain A: A.332, R.334, R.368, G.369, A.371
- Chain D: D.295
6 PLIP interactions:3 interactions with chain A, 3 interactions with chain D- Hydrogen bonds: A:A.332, A:G.369, D:D.295, D:D.295
- Salt bridges: A:R.334
- Water bridges: D:D.297
LXC.103: 11 residues within 4Å:- Chain B: F.26
- Chain D: H.54, T.90, F.94, W.137, E.181, E.217, H.220, D.245, D.287
- Ligands: CA.100
7 PLIP interactions:7 interactions with chain D- Hydrogen bonds: D:H.54, D:E.181, D:H.220
- Water bridges: D:N.215, D:N.215
- Salt bridges: D:H.54, D:K.289
- 116 x IOD: IODIDE ION(Non-functional Binders)
IOD.5: 3 residues within 4Å:- Chain A: T.12, H.49
- Ligands: IOD.6
Ligand excluded by PLIPIOD.6: 4 residues within 4Å:- Chain A: R.10, P.283
- Ligands: IOD.5, IOD.7
Ligand excluded by PLIPIOD.7: 5 residues within 4Å:- Chain A: R.10, S.281, P.283
- Ligands: IOD.6, IOD.8
Ligand excluded by PLIPIOD.8: 3 residues within 4Å:- Chain A: E.132, P.283
- Ligands: IOD.7
Ligand excluded by PLIPIOD.9: 6 residues within 4Å:- Chain A: Q.234, W.237, A.238
- Chain B: A.201, F.202
- Ligands: IOD.10
Ligand excluded by PLIPIOD.10: 4 residues within 4Å:- Chain A: A.238
- Chain B: R.205
- Ligands: IOD.9, IOD.11
Ligand excluded by PLIPIOD.11: 6 residues within 4Å:- Chain A: L.200, I.203, E.204, K.240
- Ligands: IOD.10, IOD.12
Ligand excluded by PLIPIOD.12: 5 residues within 4Å:- Chain A: E.204, P.209, K.240
- Ligands: IOD.11, IOD.13
Ligand excluded by PLIPIOD.13: 5 residues within 4Å:- Chain A: E.204, P.209, E.210, K.240
- Ligands: IOD.12
Ligand excluded by PLIPIOD.14: 6 residues within 4Å:- Chain A: F.104, G.138, M.158, F.162
- Ligands: IOD.15, IOD.18
Ligand excluded by PLIPIOD.15: 6 residues within 4Å:- Chain A: F.104, A.136, G.138
- Ligands: IOD.14, IOD.16, IOD.18
Ligand excluded by PLIPIOD.16: 5 residues within 4Å:- Chain A: T.91, L.93, A.136, W.137
- Ligands: IOD.15
Ligand excluded by PLIPIOD.17: 5 residues within 4Å:- Chain A: F.104, T.119, Y.134, A.136, L.165
Ligand excluded by PLIPIOD.18: 6 residues within 4Å:- Chain A: L.93, G.103, F.104, E.141
- Ligands: IOD.14, IOD.15
Ligand excluded by PLIPIOD.19: 5 residues within 4Å:- Chain A: D.24, P.25
- Chain C: E.186, P.187
- Ligands: IOD.20
Ligand excluded by PLIPIOD.20: 7 residues within 4Å:- Chain A: P.25, E.186, Y.254
- Chain C: P.25, E.186
- Ligands: IOD.19, IOD.86
Ligand excluded by PLIPIOD.21: 4 residues within 4Å:- Chain A: L.236, G.239, K.240, L.241
Ligand excluded by PLIPIOD.22: 3 residues within 4Å:- Chain A: H.382, G.385
- Ligands: IOD.23
Ligand excluded by PLIPIOD.23: 4 residues within 4Å:- Chain A: D.381, H.382, A.386
- Ligands: IOD.22
Ligand excluded by PLIPIOD.24: 1 residues within 4Å:- Chain A: F.94
Ligand excluded by PLIPIOD.25: 3 residues within 4Å:- Chain A: Q.41
- Ligands: IOD.26, IOD.33
Ligand excluded by PLIPIOD.26: 3 residues within 4Å:- Chain A: E.38, Q.41
- Ligands: IOD.25
Ligand excluded by PLIPIOD.27: 3 residues within 4Å:- Chain A: L.193, P.194
- Chain B: Q.234
Ligand excluded by PLIPIOD.28: 5 residues within 4Å:- Chain A: G.138, E.141, M.158, I.191, L.192
Ligand excluded by PLIPIOD.29: 3 residues within 4Å:- Chain A: N.250, G.263
- Chain D: R.266
Ligand excluded by PLIPIOD.30: 3 residues within 4Å:- Chain A: E.70, H.71, R.74
Ligand excluded by PLIPIOD.31: 2 residues within 4Å:- Chain A: N.227
- Chain B: G.146
Ligand excluded by PLIPIOD.32: 2 residues within 4Å:- Chain A: R.316, A.319
Ligand excluded by PLIPIOD.33: 2 residues within 4Å:- Chain A: R.42
- Ligands: IOD.25
Ligand excluded by PLIPIOD.38: 3 residues within 4Å:- Chain B: T.12, H.49
- Ligands: IOD.39
Ligand excluded by PLIPIOD.39: 4 residues within 4Å:- Chain B: R.10, P.283
- Ligands: IOD.38, IOD.40
Ligand excluded by PLIPIOD.40: 5 residues within 4Å:- Chain B: R.10, S.281, P.283
- Ligands: IOD.39, IOD.41
Ligand excluded by PLIPIOD.41: 3 residues within 4Å:- Chain B: E.132, P.283
- Ligands: IOD.40
Ligand excluded by PLIPIOD.42: 6 residues within 4Å:- Chain A: A.201, F.202
- Chain B: Q.234, W.237, A.238
- Ligands: IOD.43
Ligand excluded by PLIPIOD.43: 4 residues within 4Å:- Chain A: R.205
- Chain B: A.238
- Ligands: IOD.42, IOD.44
Ligand excluded by PLIPIOD.44: 6 residues within 4Å:- Chain B: L.200, I.203, E.204, K.240
- Ligands: IOD.43, IOD.45
Ligand excluded by PLIPIOD.45: 5 residues within 4Å:- Chain B: E.204, P.209, K.240
- Ligands: IOD.44, IOD.46
Ligand excluded by PLIPIOD.46: 5 residues within 4Å:- Chain B: E.204, P.209, E.210, K.240
- Ligands: IOD.45
Ligand excluded by PLIPIOD.47: 6 residues within 4Å:- Chain B: F.104, G.138, M.158, F.162
- Ligands: IOD.48, IOD.51
Ligand excluded by PLIPIOD.48: 6 residues within 4Å:- Chain B: F.104, A.136, G.138
- Ligands: IOD.47, IOD.49, IOD.51
Ligand excluded by PLIPIOD.49: 5 residues within 4Å:- Chain B: T.91, L.93, A.136, W.137
- Ligands: IOD.48
Ligand excluded by PLIPIOD.50: 5 residues within 4Å:- Chain B: F.104, T.119, Y.134, A.136, L.165
Ligand excluded by PLIPIOD.51: 6 residues within 4Å:- Chain B: L.93, G.103, F.104, E.141
- Ligands: IOD.47, IOD.48
Ligand excluded by PLIPIOD.52: 5 residues within 4Å:- Chain B: D.24, P.25
- Chain D: E.186, P.187
- Ligands: IOD.53
Ligand excluded by PLIPIOD.53: 7 residues within 4Å:- Chain B: P.25, E.186, Y.254
- Chain D: P.25, E.186
- Ligands: IOD.52, IOD.119
Ligand excluded by PLIPIOD.54: 4 residues within 4Å:- Chain B: L.236, G.239, K.240, L.241
Ligand excluded by PLIPIOD.55: 3 residues within 4Å:- Chain B: H.382, G.385
- Ligands: IOD.56
Ligand excluded by PLIPIOD.56: 4 residues within 4Å:- Chain B: D.381, H.382, A.386
- Ligands: IOD.55
Ligand excluded by PLIPIOD.57: 1 residues within 4Å:- Chain B: F.94
Ligand excluded by PLIPIOD.58: 3 residues within 4Å:- Chain B: Q.41
- Ligands: IOD.59, IOD.66
Ligand excluded by PLIPIOD.59: 3 residues within 4Å:- Chain B: E.38, Q.41
- Ligands: IOD.58
Ligand excluded by PLIPIOD.60: 3 residues within 4Å:- Chain A: Q.234
- Chain B: L.193, P.194
Ligand excluded by PLIPIOD.61: 5 residues within 4Å:- Chain B: G.138, E.141, M.158, I.191, L.192
Ligand excluded by PLIPIOD.62: 3 residues within 4Å:- Chain B: N.250, G.263
- Chain C: R.266
Ligand excluded by PLIPIOD.63: 3 residues within 4Å:- Chain B: E.70, H.71, R.74
Ligand excluded by PLIPIOD.64: 2 residues within 4Å:- Chain A: G.146
- Chain B: N.227
Ligand excluded by PLIPIOD.65: 2 residues within 4Å:- Chain B: R.316, A.319
Ligand excluded by PLIPIOD.66: 2 residues within 4Å:- Chain B: R.42
- Ligands: IOD.58
Ligand excluded by PLIPIOD.71: 3 residues within 4Å:- Chain C: T.12, H.49
- Ligands: IOD.72
Ligand excluded by PLIPIOD.72: 4 residues within 4Å:- Chain C: R.10, P.283
- Ligands: IOD.71, IOD.73
Ligand excluded by PLIPIOD.73: 5 residues within 4Å:- Chain C: R.10, S.281, P.283
- Ligands: IOD.72, IOD.74
Ligand excluded by PLIPIOD.74: 3 residues within 4Å:- Chain C: E.132, P.283
- Ligands: IOD.73
Ligand excluded by PLIPIOD.75: 6 residues within 4Å:- Chain C: Q.234, W.237, A.238
- Chain D: A.201, F.202
- Ligands: IOD.76
Ligand excluded by PLIPIOD.76: 4 residues within 4Å:- Chain C: A.238
- Chain D: R.205
- Ligands: IOD.75, IOD.77
Ligand excluded by PLIPIOD.77: 6 residues within 4Å:- Chain C: L.200, I.203, E.204, K.240
- Ligands: IOD.76, IOD.78
Ligand excluded by PLIPIOD.78: 5 residues within 4Å:- Chain C: E.204, P.209, K.240
- Ligands: IOD.77, IOD.79
Ligand excluded by PLIPIOD.79: 5 residues within 4Å:- Chain C: E.204, P.209, E.210, K.240
- Ligands: IOD.78
Ligand excluded by PLIPIOD.80: 6 residues within 4Å:- Chain C: F.104, G.138, M.158, F.162
- Ligands: IOD.81, IOD.84
Ligand excluded by PLIPIOD.81: 6 residues within 4Å:- Chain C: F.104, A.136, G.138
- Ligands: IOD.80, IOD.82, IOD.84
Ligand excluded by PLIPIOD.82: 5 residues within 4Å:- Chain C: T.91, L.93, A.136, W.137
- Ligands: IOD.81
Ligand excluded by PLIPIOD.83: 5 residues within 4Å:- Chain C: F.104, T.119, Y.134, A.136, L.165
Ligand excluded by PLIPIOD.84: 6 residues within 4Å:- Chain C: L.93, G.103, F.104, E.141
- Ligands: IOD.80, IOD.81
Ligand excluded by PLIPIOD.85: 5 residues within 4Å:- Chain A: E.186, P.187
- Chain C: D.24, P.25
- Ligands: IOD.86
Ligand excluded by PLIPIOD.86: 7 residues within 4Å:- Chain A: P.25, E.186
- Chain C: P.25, E.186, Y.254
- Ligands: IOD.20, IOD.85
Ligand excluded by PLIPIOD.87: 4 residues within 4Å:- Chain C: L.236, G.239, K.240, L.241
Ligand excluded by PLIPIOD.88: 3 residues within 4Å:- Chain C: H.382, G.385
- Ligands: IOD.89
Ligand excluded by PLIPIOD.89: 4 residues within 4Å:- Chain C: D.381, H.382, A.386
- Ligands: IOD.88
Ligand excluded by PLIPIOD.90: 1 residues within 4Å:- Chain C: F.94
Ligand excluded by PLIPIOD.91: 3 residues within 4Å:- Chain C: Q.41
- Ligands: IOD.92, IOD.99
Ligand excluded by PLIPIOD.92: 3 residues within 4Å:- Chain C: E.38, Q.41
- Ligands: IOD.91
Ligand excluded by PLIPIOD.93: 3 residues within 4Å:- Chain C: L.193, P.194
- Chain D: Q.234
Ligand excluded by PLIPIOD.94: 5 residues within 4Å:- Chain C: G.138, E.141, M.158, I.191, L.192
Ligand excluded by PLIPIOD.95: 3 residues within 4Å:- Chain B: R.266
- Chain C: N.250, G.263
Ligand excluded by PLIPIOD.96: 3 residues within 4Å:- Chain C: E.70, H.71, R.74
Ligand excluded by PLIPIOD.97: 2 residues within 4Å:- Chain C: N.227
- Chain D: G.146
Ligand excluded by PLIPIOD.98: 2 residues within 4Å:- Chain C: R.316, A.319
Ligand excluded by PLIPIOD.99: 2 residues within 4Å:- Chain C: R.42
- Ligands: IOD.91
Ligand excluded by PLIPIOD.104: 3 residues within 4Å:- Chain D: T.12, H.49
- Ligands: IOD.105
Ligand excluded by PLIPIOD.105: 4 residues within 4Å:- Chain D: R.10, P.283
- Ligands: IOD.104, IOD.106
Ligand excluded by PLIPIOD.106: 5 residues within 4Å:- Chain D: R.10, S.281, P.283
- Ligands: IOD.105, IOD.107
Ligand excluded by PLIPIOD.107: 3 residues within 4Å:- Chain D: E.132, P.283
- Ligands: IOD.106
Ligand excluded by PLIPIOD.108: 6 residues within 4Å:- Chain C: A.201, F.202
- Chain D: Q.234, W.237, A.238
- Ligands: IOD.109
Ligand excluded by PLIPIOD.109: 4 residues within 4Å:- Chain C: R.205
- Chain D: A.238
- Ligands: IOD.108, IOD.110
Ligand excluded by PLIPIOD.110: 6 residues within 4Å:- Chain D: L.200, I.203, E.204, K.240
- Ligands: IOD.109, IOD.111
Ligand excluded by PLIPIOD.111: 5 residues within 4Å:- Chain D: E.204, P.209, K.240
- Ligands: IOD.110, IOD.112
Ligand excluded by PLIPIOD.112: 5 residues within 4Å:- Chain D: E.204, P.209, E.210, K.240
- Ligands: IOD.111
Ligand excluded by PLIPIOD.113: 6 residues within 4Å:- Chain D: F.104, G.138, M.158, F.162
- Ligands: IOD.114, IOD.117
Ligand excluded by PLIPIOD.114: 6 residues within 4Å:- Chain D: F.104, A.136, G.138
- Ligands: IOD.113, IOD.115, IOD.117
Ligand excluded by PLIPIOD.115: 5 residues within 4Å:- Chain D: T.91, L.93, A.136, W.137
- Ligands: IOD.114
Ligand excluded by PLIPIOD.116: 5 residues within 4Å:- Chain D: F.104, T.119, Y.134, A.136, L.165
Ligand excluded by PLIPIOD.117: 6 residues within 4Å:- Chain D: L.93, G.103, F.104, E.141
- Ligands: IOD.113, IOD.114
Ligand excluded by PLIPIOD.118: 5 residues within 4Å:- Chain B: E.186, P.187
- Chain D: D.24, P.25
- Ligands: IOD.119
Ligand excluded by PLIPIOD.119: 7 residues within 4Å:- Chain B: P.25, E.186
- Chain D: P.25, E.186, Y.254
- Ligands: IOD.53, IOD.118
Ligand excluded by PLIPIOD.120: 4 residues within 4Å:- Chain D: L.236, G.239, K.240, L.241
Ligand excluded by PLIPIOD.121: 3 residues within 4Å:- Chain D: H.382, G.385
- Ligands: IOD.122
Ligand excluded by PLIPIOD.122: 4 residues within 4Å:- Chain D: D.381, H.382, A.386
- Ligands: IOD.121
Ligand excluded by PLIPIOD.123: 1 residues within 4Å:- Chain D: F.94
Ligand excluded by PLIPIOD.124: 3 residues within 4Å:- Chain D: Q.41
- Ligands: IOD.125, IOD.132
Ligand excluded by PLIPIOD.125: 3 residues within 4Å:- Chain D: E.38, Q.41
- Ligands: IOD.124
Ligand excluded by PLIPIOD.126: 3 residues within 4Å:- Chain C: Q.234
- Chain D: L.193, P.194
Ligand excluded by PLIPIOD.127: 5 residues within 4Å:- Chain D: G.138, E.141, M.158, I.191, L.192
Ligand excluded by PLIPIOD.128: 3 residues within 4Å:- Chain A: R.266
- Chain D: N.250, G.263
Ligand excluded by PLIPIOD.129: 3 residues within 4Å:- Chain D: E.70, H.71, R.74
Ligand excluded by PLIPIOD.130: 2 residues within 4Å:- Chain C: G.146
- Chain D: N.227
Ligand excluded by PLIPIOD.131: 2 residues within 4Å:- Chain D: R.316, A.319
Ligand excluded by PLIPIOD.132: 2 residues within 4Å:- Chain D: R.42
- Ligands: IOD.124
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Evans, G. et al., Triiodide Derivatization and Combinatorial Counter-Ion Replacement: Two Methods for Enhancing Phasing Signal Using Laboratory Cu Kalpha X-Ray Equipment. Acta Crystallogr.,Sect.D (2002)
- Release Date
- 2002-06-06
- Peptides
- XYLOSE ISOMERASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.55 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x CA: CALCIUM ION(Non-covalent)
- 8 x LXC: beta-L-xylopyranose(Non-covalent)
- 116 x IOD: IODIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Evans, G. et al., Triiodide Derivatization and Combinatorial Counter-Ion Replacement: Two Methods for Enhancing Phasing Signal Using Laboratory Cu Kalpha X-Ray Equipment. Acta Crystallogr.,Sect.D (2002)
- Release Date
- 2002-06-06
- Peptides
- XYLOSE ISOMERASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A